Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,303 INR | +0.70% | -0.45% | -3.89% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.89% | 1.18B | |
+16.93% | 42.79B | |
+22.20% | 22.81B | |
+16.96% | 15.04B | |
+18.51% | 14.49B | |
+51.63% | 12.65B | |
-0.05% | 6.79B | |
-11.45% | 6.74B | |
-8.87% | 5.73B | |
+14.55% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q1 2023 Earnings Call, Aug 05, 2022